NCT04415905

Brief Summary

Caudal block is commonly used for postoperative analgesia in paediatric patients. A higher volume (1.5 ml/kg) of local anaesthetic for caudal block has been reported to not only increase the level of cranial spread but also provide better quality and longer duration of analgesia in comparison with the conventional volume (1.0 ml/kg). However, caudal block with a high volume of local anaesthetic can increase intracranial pressure (ICP). Previous studies have shown that propofol anesthesia lowers ICP when compared with volatile anesthesia. Therefore, this study was designed to test if propofol can reduce the magnitude of ICP increase following caudal block when compared with a volatile anesthetic, sevoflurane. There is increasing evidence that optic nerve sheath diameter (ONSD) measured by ultrasonography correlates with degree of ICP and is able to detect intracranial hypertension. Therefore, ONSD will be measured as a surrogate of ICP.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 28, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 4, 2020

Completed
18 days until next milestone

Study Start

First participant enrolled

June 22, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 2, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2022

Completed
Last Updated

May 5, 2022

Status Verified

May 1, 2022

Enrollment Period

1.7 years

First QC Date

May 28, 2020

Last Update Submit

May 4, 2022

Conditions

Keywords

Caudal blockIntracranial pressurePropofolSevofluraneUltrasound

Outcome Measures

Primary Outcomes (4)

  • ONSD

    ONSD is a surrogate for ICP. ONSD was measured by transorbital sonography. Transorbital sonography is performed using a linear 6-13 Hz probe. After applying a thick layer of sterile coupling gel on the closed upper eyelid, the probe is placed gently without exerting pressure. Axial images of the orbit are acquired in the plane of the optic nerve, and ONSD is measured 3mm posterior to the optic nerve head as described previously.

    before (T0) caudal block.

  • ONSD

    ONSD is a surrogate for ICP. ONSD was measured by transorbital sonography. Transorbital sonography is performed using a linear 6-13 Hz probe. After applying a thick layer of sterile coupling gel on the closed upper eyelid, the probe is placed gently without exerting pressure. Axial images of the orbit are acquired in the plane of the optic nerve, and ONSD is measured 3mm posterior to the optic nerve head as described previously.

    immediately after (T1) caudal block.

  • ONSD

    ONSD is a surrogate for ICP. ONSD was measured by transorbital sonography. Transorbital sonography is performed using a linear 6-13 Hz probe. After applying a thick layer of sterile coupling gel on the closed upper eyelid, the probe is placed gently without exerting pressure. Axial images of the orbit are acquired in the plane of the optic nerve, and ONSD is measured 3mm posterior to the optic nerve head as described previously.

    10 minutes (T2) after caudal block.

  • ONSD

    ONSD is a surrogate for ICP. ONSD was measured by transorbital sonography. Transorbital sonography is performed using a linear 6-13 Hz probe. After applying a thick layer of sterile coupling gel on the closed upper eyelid, the probe is placed gently without exerting pressure. Axial images of the orbit are acquired in the plane of the optic nerve, and ONSD is measured 3mm posterior to the optic nerve head as described previously.

    30 minutes (T3) after caudal block.

Secondary Outcomes (28)

  • The variables affecting ICP : Heart rate (beats per minute)

    before (T0) caudal block.

  • The variables affecting ICP : Heart rate (beats per minute)

    immediately after (T1) caudal block.

  • The variables affecting ICP : Heart rate (beats per minute)

    10 minutes (T2) after caudal block.

  • The variables affecting ICP : Heart rate (beats per minute)

    30 minutes (T3) after caudal block.

  • The variables affecting ICP : Mean arterial pressure (mmHg)

    before (T0) caudal block.

  • +23 more secondary outcomes

Study Arms (2)

group P

EXPERIMENTAL

The participants in the group P are anesthetized with propofol.

Drug: Propofol

group S

ACTIVE COMPARATOR

The participants in the group S are anesthetized with sevoflurane.

Drug: Sevoflurane

Interventions

The participants in the group P are anesthetized with propofol

group P

The participants in the group S are anesthetized with sevoflurane.

group S

Eligibility Criteria

Age3 Years - 5 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Among children undergoing urological surgery, patients, 36 to 72-months-old
  • Body weight less than 20 kg (The limit on body weight is set because the maximum volume of local anaesthetic for caudal block in children is restricted to 30 ml.)
  • Treatment plan for caudal block for analgesia, are enrolled.

You may not qualify if:

  • Symptoms or signs of spinal anomalies or infection at the sacral region
  • Coagulopathy
  • Increased ICP
  • Ophthalmic diseases
  • History of increased ICP

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine

Seoul, South Korea

Location

MeSH Terms

Interventions

PropofolSevoflurane

Intervention Hierarchy (Ancestors)

PhenolsBenzene DerivativesHydrocarbons, AromaticHydrocarbons, CyclicHydrocarbonsOrganic ChemicalsMethyl EthersEthersHydrocarbons, FluorinatedHydrocarbons, Halogenated

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Anesthesia machine and infusion pumps are shielded from assessors who measure ONSD.
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: There are 2 groups according to the type of main anesthetic agent. P group are anesthetized with propofol, so are S group with sevoflurane.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2020

First Posted

June 4, 2020

Study Start

June 22, 2020

Primary Completion

March 2, 2022

Study Completion

March 2, 2022

Last Updated

May 5, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will not share

Locations